Source: EURLEX
Language: en
Format: md

|  |  |  |
| --- | --- | --- |
| European flag | Official Journal  of the European Union | EN  Series C |

---

|  |  |  |
| --- | --- | --- |
|  | C/2024/738 | 22.1.2024 |

Judgment of the General Court of 15 November 2023 — Laboratorios Normon v EUIPO — Sofar (NORMOCARE)

(Case T-19/23) [(1)](#ntr1-C_202400738EN.000101-E0001)

(EU trade mark - Invalidity proceedings - EU word mark NORMOCARE - Earlier national word mark NOMOR - Relative ground for invalidity - Article 60(1)(a) and Article 8(1)(b) of Regulation (EU) 2017/1001)

(C/2024/738)

Language of the case: English

Parties

Applicant: Laboratorios Normon, SA (Tres Cantos, Spain) (represented by: I. González-Mogena González, lawyer)

Defendant: European Union Intellectual Property Office (represented by: N. Lamsters and T. Frydendahl, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO: Sofar SpA, (Trezzano Rosa, Italy)

Re:

By its action under Article 263 TFEU, the applicant seeks the annulment of the decision of the First Board of Appeal of the European Union Intellectual Property Office (EUIPO) of 26 October 2022 (Case R 916/2022-1).

Operative part of the judgment

The Court:

|  |  |
| --- | --- |
| 1. | Dismisses the action; |

|  |  |
| --- | --- |
| 2. | Orders Laboratorios Normon, SA and the European Union Intellectual Property Office (EUIPO) to bear their own costs. |

---

---

ELI: http://data.europa.eu/eli/C/2024/738/oj

ISSN 1977-091X (electronic edition)

---

[Top](#document1)